Nationwide survey on the prevalence of anti-tuberculosis drug resistance in the Republic of Yemen, 2004

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 12, 2007, Pages 1328-1333

  Al Akhali, A ^a   Ohkado, Akihiro ^b   Fujiki, A ^b   Mitarai, S ^b   Yamada, N ^b   Masui, T ^c   Otomo, K ^b   Yamada, H ^b   Seita, A ^d   Mori, T ^e   Al Absi, A N ^f  

^a National Tuberculosis Institute   (Yemen)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^c AICHI PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d WHO Regional Office for the Eastern Mediterranean   (Egypt)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f National Tuberculosis Control Programme   (Yemen)

Author keywords

Anti tuberculosis drugs; Drug susceptibility testing; Prevalence survey; Tuberculosis; Yemen

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS; YEMEN;

ADULT; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; YEMEN;

EID: 37549072231     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. United Nations Population Fund. Preliminarily results of Yemen 2004 population and housing census. Sana'a, Yemen: UNFPA, http://yemen.unfpa.org/ News/Population-Census.htm Accessed September 2007.
2. Ministry of Public Health. Report on the nationwide tuberculin survey among school children in Yemen. Sana'a, Yemen: Ministry of Public Health, 1991.
3. World Health Organization. Framework for effective tuberculosis control. WHO/TB/94.179. Geneva, Switzerland: WHO, 1994.
4. Masui T. Mission report tuberculosis control in the Republic of Yemen 16 February-4 March 2005. Tokyo, Japan: Japan International Cooperation Agency, 2005.
5. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 1998; 2: 72-89.
6. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/2003.320. Geneva, Switzerland: WHO, 2003.
7. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world. Report no. 2. Prevalence and Trends. Geneva, Switzerland: WHO, 2000.
8. Fujiki A. TB bacteriology examination to stop TB. Tokyo, Japan: Research Institute of Tuberculosis, 2001.
9. Abe C, Aono C, Hirano K. Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media. Kekkaku 2001; 76: 657-662. [Japanese, abstract in English]
10. Altman D G, Machin D, Bryant T N, Gardner S, eds. Statistics with confidence. 2nd ed. Bristol, UK: British Medical Journal, 2001.
11. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world. Report no. 3. Geneva, Switzerland: WHO, 2004.
12. World Health Organization/International Union Against Tuberculosis and Lung Disease. Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world. Report no. 1. Geneva, Switzerland: WHO, 1997.
13. Watterson S, Wilson S M, Yates M D, et al. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-1973.